SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-23-000077
Filing Date
2023-11-01
Accepted
2023-10-31 18:41:49
Documents
12
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 6-K a2023-10x31appendix4c.htm 6-K 20502
2 EX-99.1 exhibit991appendix4c.htm EX-99.1 28578
3 exhibit991appendix4c001.jpg GRAPHIC 279569
4 exhibit991appendix4c002.jpg GRAPHIC 288558
5 exhibit991appendix4c003.jpg GRAPHIC 208813
6 exhibit991appendix4c004.jpg GRAPHIC 122349
7 exhibit991appendix4c005.jpg GRAPHIC 125804
8 exhibit991appendix4c006.jpg GRAPHIC 103112
9 exhibit991appendix4c007.jpg GRAPHIC 111445
10 exhibit991appendix4c008.jpg GRAPHIC 214212
11 exhibit991appendix4c009.jpg GRAPHIC 163039
12 exhibit991appendix4c010.jpg GRAPHIC 118705
  Complete submission text file 0001345099-23-000077.txt   2441448
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 231366070
SIC: 2836 Biological Products, (No Diagnostic Substances)